Innate immune dysregulation in monocytes in sickle cell disease

Authors: Sarah Hinderstein, Gemma Vidal-Pedrola, Subhasis Mohanty, Irene Matos, Fanny Alarcon, Judith Carbonella, Cecelia Calhoun, Lakshmanan Krishnamurti, Albert Shaw, Inci Yildirim

Published: November 3, 2025

Click Here to Read More
Previous
Previous

Role of Menstrual Bleeding Assessments in Sickle Cell Clinics

Next
Next

Revisiting acute chest syndrome (ACS) associated with sickle cell disease (SCD) vaso-occlusive pain episodes (VOE): Insight from a prospective, multicenter Phase-3 randomized controlled trial